New 52 Week High Today

Bausch Health Companies Inc BHC:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
10.60quote price arrow down-0.01 (-0.09%)
Volume
62,735
Close
10.61UNCH (UNCH)
Volume
3,750,902
52 week range
5.57 - 10.80
Loading...
  • Open10.46
  • Day High10.80
  • Day Low10.45
  • Prev Close10.49
  • 52 Week High10.80
  • 52 Week High Date03/28/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap3.83B
  • Shares Out360.99M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change32.29

KEY STATS

  • Open10.46
  • Day High10.80
  • Day Low10.45
  • Prev Close10.49
  • 52 Week High10.80
  • 52 Week High Date03/28/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23
  • Market Cap3.83B
  • Shares Out360.99M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change32.29

RATIOS/PROFITABILITY

  • EPS (TTM)-1.62
  • P/E (TTM)-6.54
  • Fwd P/E (NTM)2.71
  • EBITDA (TTM)2.863B
  • ROE (TTM)-441.96%
  • Revenue (TTM)8.757B
  • Gross Margin (TTM)70.78%
  • Net Margin (TTM)-6.98%
  • Debt To Equity (MRQ)-2,190.61%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date05/18/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

Related Video

Thursday, Feb. 22, 2024: The Investing Club breaks down the big earnings win from this chip holding
VIDEO10:3410:34
Thursday, Feb. 22, 2024: The Investing Club breaks down the big earnings win from this chip holding

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada

Top Peers

SYMBOLLASTCHG%CHG
BHC
Bausch Health Companies Inc
10.61UNCHUNCH
GUD
CPH
HLS
RX
Biosyent Inc
8.70UNCHUNCH